Nearly all of the genes encoding the established coagulation and fibrinolyt
ic factors have been successfully altered or disrupted in transgenic mice.
Although comprehensive studies of each of these gene-targeted mouse lines a
re still ongoing, the initial findings have significantly refined our under
standing of the roles of selected hemostatic factors in vivo, and occasiona
lly altered long-standing concepts. This review summarizes some of the prog
ress that has been made in the generation and phenotypic characterization o
f mice lacking key hemostatic factors, including coagulation, fibrinolytic,
platelet and endothelial cell-associated factors. New insights regarding t
he role(s) and interplay of hemostatic factors that have emerged from detai
led studies of mice carrying multiple deficits in coagulation and fibrinoly
tic system components are highlighted.